Skip to main content
. 2021 Jun 1;5(6):e572. doi: 10.1097/HS9.0000000000000572

Figure 1.

Figure 1.

Possible treatment algorithm in relapsed/refractory AML patients. AML = acute myeloid leukemia; DLI = donor lymphocyte infusions; FLT3 = fms-related tyrosine kinase 3; HLA = human leukocyte antigen; HMA = hypomethylating agent; HSCT = hematopoietic stem cell transplantation; HU = hydroxyurea; IDH = isocitrate dehydrogenase; LDAC = low-dose cytarabine; mut = mutated; Tx = transplantation.